rpl3802 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The RPL38 antibody is a polyclonal immunoglobulin (IgG) used in molecular biology research to detect the ribosomal protein L38 (RPL38), a critical component of the 60S ribosomal subunit. RPL38 plays a central role in ribosome biogenesis, protein synthesis, and cellular growth regulation. This antibody is widely employed in techniques such as Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) to study RPL38 expression and its implications in disease states .

Structure and Function of RPL38

RPL38 is an 8 kDa protein localized to the cytoplasm, cytosol, and ribosomes. It facilitates ribosome assembly and protein translation, with emerging evidence linking its dysregulation to cancer progression and autoimmune disorders . The antibody targets a recombinant fusion protein corresponding to amino acids 1–70 of human RPL38 (NP_000990.1), ensuring high specificity for human, mouse, and rat samples .

Cancer Research

RPL38 is overexpressed in various cancers, including breast and colon tumors, making it a potential biomarker . Studies using RPL38 antibodies have demonstrated its utility in:

  • Ribosome dynamics: Investigating how RPL38 modulates translation efficiency in tumor cells .

  • Therapeutic targeting: Monoclonal antibodies (e.g., trastuzumab) leverage RPL38 as a surrogate marker for ribosomal activity in targeted therapies .

Autoimmune Diseases

Autoantibodies to RPL38-derived epitopes (e.g., aa 229–243) are associated with systemic sclerosis (SSc). A 2019 study found that detecting these autoantibodies improves SSc diagnosis sensitivity, highlighting RPL38’s role in autoimmune pathogenesis .

Neurological Disorders

RPL38 antibodies have been used to study ribosomal dysfunction in neurodegenerative diseases, including Alzheimer’s disease, where altered ribosome biogenesis correlates with amyloid precursor protein metabolism .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
rpl3802 antibody; rpl38 antibody; rpl38b antibody; SPAC30D11.12 antibody; 60S ribosomal protein L38-2 antibody
Target Names
rpl3802
Uniprot No.

Q&A

What is RPL38 and why is it significant in research?

RPL38 functions as a component of the large ribosomal subunit within the ribonucleoprotein complex responsible for cellular protein synthesis. Its significance extends beyond structural roles, as RPL38 has been implicated in selective translation of specific mRNAs, particularly Hox mRNAs crucial for vertebrate development . The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell . Research into RPL38 provides valuable insights into ribosomal biogenesis, translational regulation, and developmental processes, making it an important target for developmental biology and cancer research.

What are the primary applications for RPL38 antibodies in research?

RPL38 antibodies serve multiple research applications, with validated uses including:

ApplicationTypical DilutionExpected ResultsTechnical Considerations
Western Blot (WB)1:1000Single band at ~8 kDaPredicted band size: 8 kDa
Immunocytochemistry/ Immunofluorescence (ICC/IF)1:100Nuclear/nucleolar and cytoplasmic stainingValidated in HeLa cells
Immunohistochemistry (IHC)1:50-1:200Tissue-specific expression patternsMay require optimization for each tissue type
Immunoprecipitation (IP)1:50-1:100Isolation of RPL38 and associated complexesLess commonly validated

The choice of application should align with specific research objectives and experimental design requirements .

How should researchers validate the specificity of RPL38 antibodies?

Proper validation ensures experimental reliability and reproducibility. Recommended validation approaches include:

  • Genetic validation: Testing in RPL38 knockout/knockdown models (using CRISPR-Cas9, siRNA) to confirm signal loss

  • Positive controls: Using cell lines with known RPL38 expression (e.g., HeLa cells as demonstrated in the literature)

  • Technical controls: Including secondary-antibody-only controls to detect non-specific binding

  • Cross-technique validation: Confirming consistent results across multiple detection methods

  • Peptide competition: Pre-incubating the antibody with immunizing peptide to block specific binding

For polyclonal antibodies like the rabbit polyclonal anti-RPL38 (ab236880), batch-to-batch variation should be considered when planning long-term studies .

How can RPL38 antibodies be optimized for different cell types and applications?

Optimization is essential for obtaining reliable and reproducible results across different experimental systems:

Western Blot Optimization:

  • Start with manufacturer-recommended dilution (e.g., 1:1000 for ab236880)

  • Perform titration experiments with different antibody concentrations

  • For whole cell lysates (e.g., EC109), ensure complete protein extraction using appropriate lysis buffers

  • Verify transfer efficiency, especially for low molecular weight proteins like RPL38 (~8 kDa)

Immunofluorescence Optimization:

  • Begin with validated dilutions (e.g., 1:100 for HeLa cells)

  • Test multiple fixation methods (paraformaldehyde vs. methanol)

  • Optimize permeabilization conditions to ensure antibody access to nuclear/nucleolar compartments

  • Consider antigen retrieval methods for tissue sections

  • Select appropriate secondary antibodies (e.g., Alexa-Fluor®488-conjugated Goat Anti-Rabbit IgG)

Systematic optimization should include documentation of all variables and include appropriate controls in each experiment.

How do subcellular localization studies with RPL38 antibodies inform ribosomal research?

RPL38's dynamic localization provides insights into ribosome biogenesis and function:

Subcellular CompartmentExpected RPL38 LocalizationSignificanceImaging Considerations
NucleolusHigh concentrationSite of ribosome assemblyCo-staining with nucleolar markers recommended
NucleoplasmModerate signalTransit of pre-60S particlesDistinguish from nucleolar signal
CytoplasmDiffuse signalMature ribosomes actively translatingHeLa cells show both nucleolar and cytoplasmic staining
Specific cytoplasmic fociPotential concentrationSpecialized translation sitesSuper-resolution techniques beneficial

Advanced imaging approaches, such as confocal microscopy with Z-stack analysis, can differentiate between these compartments. The observed dual localization of RPL38 in both nuclear and cytoplasmic compartments reflects its role in ribosome biogenesis and function .

What are the most effective troubleshooting strategies for inconsistent RPL38 antibody results?

Inconsistent results often stem from multiple sources. A systematic approach includes:

Sample Preparation Issues:

  • Ensure complete lysis for protein extraction (particularly important for nuclear proteins)

  • Use fresh samples with appropriate protease inhibitors

  • Standardize sample collection and processing

Antibody-Related Factors:

  • Avoid repeated freeze-thaw cycles of antibody aliquots

  • Verify antibody storage conditions (-20°C for long-term storage)

  • Test different lot numbers if inconsistencies persist

Technical Variables:

  • For Western blotting: Optimize transfer conditions for small proteins (~8 kDa)

  • For ICC/IF: Test different fixation and permeabilization methods

  • Standardize incubation times and temperatures

When troubleshooting, change only one variable at a time and document all conditions systematically to identify the source of inconsistency.

How can RPL38 antibodies contribute to studies of translational regulation?

RPL38 has specialized roles in translational control, particularly for specific mRNAs:

Experimental Approaches:

  • Combine RPL38 immunoprecipitation with RNA sequencing to identify associated transcripts

  • Use proximity labeling techniques (BioID, APEX) with RPL38 antibodies to identify interaction partners

  • Perform polysome profiling with RPL38 antibody detection to examine its association with actively translating ribosomes

  • Correlate RPL38 levels with translation of specific mRNAs using reporter assays

These approaches can reveal how RPL38 contributes to specialized translation functions beyond its structural role in the ribosome.

How do post-translational modifications affect RPL38 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition:

Modification TypePotential Effect on Antibody RecognitionExperimental Approach
PhosphorylationMay mask epitope or create conformational changesCompare detection before/after phosphatase treatment
UbiquitinationCan affect protein stability and detectionUse proteasome inhibitors to stabilize modified forms
AcetylationMay alter epitope accessibilityCompare detection in presence/absence of deacetylase inhibitors
Protein-protein interactionsCan occlude antibody binding sitesUse different lysis conditions to disrupt interactions

Researchers should be aware that detection patterns may vary under different cellular conditions that affect RPL38 modifications.

What considerations are important when studying RPL38 across different species?

The evolutionary conservation of RPL38 affects antibody applications across species:

Key Considerations:

  • Epitope conservation: Compare the immunogen sequence with target species

  • Validation status: Check if the antibody is validated in your species of interest

  • Appropriate controls: Include samples from species with known reactivity

  • Cross-reactivity testing: Perform preliminary validation in new species

How can super-resolution microscopy enhance RPL38 localization studies?

Conventional microscopy may not fully resolve the detailed localization of RPL38 within subcellular compartments. Super-resolution approaches offer significant advantages:

TechniqueResolutionAdvantages for RPL38 Studies
STED microscopy~50nmResolves nucleolar subcompartments where RPL38 localizes
STORM/PALM~20nmCan distinguish individual ribosomes
SIM~100nmGood for live-cell imaging of RPL38 dynamics
Expansion microscopy~70nmWorks with standard confocal microscopes

For optimal results with super-resolution techniques, antibody specificity becomes even more critical, and specialized sample preparation protocols may be necessary.

What multiplexing strategies can combine RPL38 detection with other ribosomal markers?

Multiplexed detection provides context for RPL38 function within the ribosomal machinery:

Effective Multiplexing Approaches:

  • Sequential immunostaining with RPL38 and other ribosomal proteins

  • Multi-color immunofluorescence combining RPL38 with nucleolar markers

  • Proximity ligation assays (PLA) to detect interactions between RPL38 and other proteins

  • Combined immunofluorescence and RNA FISH to correlate RPL38 localization with specific mRNAs

When designing multiplexed experiments, consider antibody species compatibility, fluorophore selection to minimize spectral overlap, and appropriate controls for each marker.

How can quantitative image analysis enhance RPL38 antibody-based research?

Modern image analysis tools can extract quantitative data from RPL38 immunostaining:

Quantitative Approaches:

  • Measure relative intensity of RPL38 staining across different cellular compartments

  • Track dynamic changes in RPL38 localization during cell cycle or stress responses

  • Analyze co-localization coefficients between RPL38 and other markers

  • Perform single-particle tracking in live cells with fluorescently tagged RPL38

These quantitative approaches transform descriptive observations into measurable parameters that can be statistically analyzed.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.